Yüklüyor......
Metformin causes cancer cell death through downregulation of p53-dependent differentiated embryo chondrocyte 1
BACKGROUND: Metformin is the most commonly used first-line medicine for type II diabetes mellitus. Acting via AMP-activated protein kinase, it has been used for more than 60 years and has an outstanding safety record. Metformin also offers protection against cancer, but its precise mechanisms remain...
Kaydedildi:
| Yayımlandı: | J Biomed Sci |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6238313/ https://ncbi.nlm.nih.gov/pubmed/30442142 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-018-0478-5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|